Countdown to ISU 2026
OCTOBER 1
Days
- :
Hrs
- :
Min
- :
Sec
ePoster Gallery
Investigating Genetic Testing for Primary Hyperoxaluria in Patients with Elevated Urine Oxalate
Regan Galante
McMaster University
Nephrocalcinosis – A Radiological Finding Worthy of Genetic Testing
Robert Hanna
Nephrolithiasis in a Brazilian ADPKD Cohort
Daniel da Rocha M.D., PhD
Universidade Federal de São Paulo
Objectively Measured Sleep Duration and Incident Kidney Stone Disease: The Multi-Ethnic Study of Atherosclerosis
Joseph Crivelli MD, MSPH
University of Alabama Birmingham
Organic matrix and kidney stones: Examining the role of near-neutral proteins in calcium oxalate aggregation
Brenna Knight PhD
Medical College of Wisconsin
PreciLITH: A Kidney Stone Disease Cohort with Standardized Phenotyping and Biobank for Future Molecular Studies
François Brazier MD, PhD
CHU Amiens Picardie, Université de Picardie Jules Verne
Predictors of Stone Recurrence in the NOSTONE Trial
Daniel Fuster MD
Inselspital, Bern University Hospital, University of Bern,
Protein phosphorylation is diminished in calcium oxalate stone matrix
Jeffrey Wesson MD, PhD
Medical College of Wisconsin
Survey of Audience Members at Lectures on Climate Change and Kidney Health
Frank Modersitzki MPH
NYU Langone Health
The EMPASTONE trial: Randomized controlled trial to assess efficacies of EMPAgliflozin and personalized dietary counseling for kidney STONE prevention in patients with recurrent calcium kidney stones
Samuel Christen
Inselspital, Bern University Hospital, University of Bern
The Hidden Cost of Green: Vegan-induced Severe Hyperoxaluria – a case report
Ita Heilberg MD, PhD
Federal University of São Paulo (UNIFESP)
The risk of future symptomatic stone episodes with incidentally detected asymptomatic kidney stones
Charat Thongprayoon MD
Mayo Clinic